http://www.epmmagazine.com/news/index.rss News and updates from the global pharmaceutical sector. en-us © 2015 Rapid Life Sciences Ltd, a Rapid News Communications Group Company. All Rights Reserved. Thu, 10 Sep 2015 16:26:47 GMT Event: Professor Stephen Hawking will open the inaugural Cambridge Rare Disease Summit, at the Cambridge Judge Business School on Monday 14 September http://www.epmmagazine.com/news/stephen-hawking-to-open-rare-disease-summit/ http://www.epmmagazine.com/news/stephen-hawking-to-open-rare-disease-summit/ Thu, 10 Sep 2015 16:26:47 GMT Varenicline helps smokers to quit but does not increase their risk of heart attack and depression says research published in The Lancet Respiratory Medicine http://www.epmmagazine.com/news/quit-smoking-drug-does-not-lead-to-heart-disease-or-depressi/ http://www.epmmagazine.com/news/quit-smoking-drug-does-not-lead-to-heart-disease-or-depressi/ Thu, 10 Sep 2015 14:23:33 GMT Researchers at Columbia University in New York have developed a method that can target delivery of very small volumes of drugs into the lung http://www.epmmagazine.com/news/new-delivery-method-gets-drugs-into-the-lungs/ http://www.epmmagazine.com/news/new-delivery-method-gets-drugs-into-the-lungs/ Thu, 10 Sep 2015 10:24:10 GMT RTP Company, a compounder of custom engineered thermoplastics, is offering tribology data from a friction test to help designers of drug delivery devices select the best possible material for single-use applications http://www.epmmagazine.com/news/tribology-data-available-for-medical-device-material-selecti/ http://www.epmmagazine.com/news/tribology-data-available-for-medical-device-material-selecti/ Thu, 10 Sep 2015 09:58:16 GMT A minimally invasive vaccine that combines cancer cells and immune-enhancing factors promises to “launch a destructive attack” on tumors http://www.epmmagazine.com/news/vaccine-attacks-cancer-tumors/ http://www.epmmagazine.com/news/vaccine-attacks-cancer-tumors/ Thu, 10 Sep 2015 09:35:00 GMT The Food and Drug Administration (FDA) has granted fast track designation for Motif Bio’ iclaprim intravenous (IV) drug to treat acute bacterial skin and skin structure infections (ABSSSI) and hospital acquired bacterial pneumonia (HABP) http://www.epmmagazine.com/news/fda-grants-fast-track-designation-for-iclaprim/ http://www.epmmagazine.com/news/fda-grants-fast-track-designation-for-iclaprim/ Wed, 09 Sep 2015 15:56:00 GMT An anti-overdose drug nasal spray has been submitted for expedited review by the Food and Drug Administration (FDA) http://www.epmmagazine.com/news/anti-overdose-nasal-spray-on-fda-fast-track/ http://www.epmmagazine.com/news/anti-overdose-nasal-spray-on-fda-fast-track/ Tue, 08 Sep 2015 11:21:36 GMT Nanoengineers from the nanoengineering department at the University of California, San Diego (UC San Diego) have created 3D printed micro robots in the form of a small fish, called micro fish, as a proof-of-concept for detoxing and sensing toxins http://www.epmmagazine.com/news/microfish-act-as-proof-of-concept-for-sensing-toxins/ http://www.epmmagazine.com/news/microfish-act-as-proof-of-concept-for-sensing-toxins/ Tue, 08 Sep 2015 10:23:00 GMT BioInfect will take place on 10 November 2015 at Alderley Park, Cheshire http://www.epmmagazine.com/news/event-bioinfect/ http://www.epmmagazine.com/news/event-bioinfect/ Mon, 07 Sep 2015 11:54:00 GMT Novartis has acquired all remaining rights to GlaxoSmithKline’s (GSK) Ofatumumab http://www.epmmagazine.com/news/novartis-acquires-drug-to-develop-treatment-for-ms/ http://www.epmmagazine.com/news/novartis-acquires-drug-to-develop-treatment-for-ms/ Mon, 07 Sep 2015 11:42:16 GMT Sartorius Stedim Biotech (SSB) and GE Healthcare’s Life Sciences business (GE), have entered into a worldwide OEM supply agreement for SSB’s membrane adsorber purification technology, Sartobind http://www.epmmagazine.com/news/ssb-and-ge-sign-worldwide-supply-agreement/ http://www.epmmagazine.com/news/ssb-and-ge-sign-worldwide-supply-agreement/ Mon, 07 Sep 2015 11:22:01 GMT HRA Pharma UK and Ireland has launched ellaonepharmacist.co.uk http://www.epmmagazine.com/news/hra-pharma-launches-online-resource-for-pharmacists/ http://www.epmmagazine.com/news/hra-pharma-launches-online-resource-for-pharmacists/ Mon, 07 Sep 2015 11:09:22 GMT The US Food and Drug Association (FDA) expands use of Novartis drug Promacta to include treatment of children ages one and older with chronic immune thrombocytopenia (ITP) http://www.epmmagazine.com/news/fda-approves-drug-to-treat-children-with-itp/ http://www.epmmagazine.com/news/fda-approves-drug-to-treat-children-with-itp/ Mon, 07 Sep 2015 10:47:56 GMT Kymab, a Cambridge-based antibodies-to-medicines company, is featured in the top ten of The Sunday Times Tech Track ‘Ones to Watch’ 2015 list http://www.epmmagazine.com/news/kymab-biotech-company-that-is-one-to-watch/ http://www.epmmagazine.com/news/kymab-biotech-company-that-is-one-to-watch/ Mon, 07 Sep 2015 09:33:00 GMT The extent of data breaches in the pharmaceutical sector has been revealed with almost one quarter being hacked and 60% admitting to losing important data http://www.epmmagazine.com/news/data-breaches-in-the-pharmaceutical-sector-at-60/ http://www.epmmagazine.com/news/data-breaches-in-the-pharmaceutical-sector-at-60/ Fri, 04 Sep 2015 15:03:35 GMT Emily Hughes Emily Hughes looks at how scientists in the US have designed a single pill made from a polymer gel that could deliver an entire treatment in a single dose http://www.epmmagazine.com/news/single-polymer-pill-to-deliver-entire-drug-course/ http://www.epmmagazine.com/news/single-polymer-pill-to-deliver-entire-drug-course/ Thu, 03 Sep 2015 11:05:59 GMT Heart failure medicine LCZ696 (sacubitril valsartan) will be available to the NHS under the Early Access to Medicines Scheme (EAMS) http://www.epmmagazine.com/news/eams-makes-novartis-heart-failure-medicine-available-to-nhs/ http://www.epmmagazine.com/news/eams-makes-novartis-heart-failure-medicine-available-to-nhs/ Wed, 02 Sep 2015 15:11:41 GMT Novartis drug Odomzo gains approval for locally advanced basal cell carcinoma, providing non-invasive therapy for patients http://www.epmmagazine.com/news/odomzo-gains-approval-to-treat-labcc/ http://www.epmmagazine.com/news/odomzo-gains-approval-to-treat-labcc/ Wed, 02 Sep 2015 11:35:00 GMT Sanofi and the life sciences team at Google are teaming up to improve care and outcomes for people with type 1 and type 2 diabetes http://www.epmmagazine.com/news/sanofi-and-google-life-sciences-to-improve-diabetes-health/ http://www.epmmagazine.com/news/sanofi-and-google-life-sciences-to-improve-diabetes-health/ Tue, 01 Sep 2015 14:39:26 GMT Research finds rising incidence of diabetes is behind changing market conditions for glycemic control drugs http://www.epmmagazine.com/news/re-shaping-the-landscape-for-glycemic-control/ http://www.epmmagazine.com/news/re-shaping-the-landscape-for-glycemic-control/ Fri, 28 Aug 2015 10:31:00 GMT A group of scientists are developing a new class of compounds called “micelle sequestrant polymers,” or MSPs, that could prevent fat particles from getting absorbed in the body. http://www.epmmagazine.com/news/polymer-drug-could-prevent-obesity/ http://www.epmmagazine.com/news/polymer-drug-could-prevent-obesity/ Thu, 27 Aug 2015 16:55:00 GMT A UK man is sentenced to 16 months’ imprisonment for the illegal sale of erectile dysfunction drugs following an investigation by MHRA http://www.epmmagazine.com/news/man-jailed-for-illegal-erectile-dysfunction-drug-sales/ http://www.epmmagazine.com/news/man-jailed-for-illegal-erectile-dysfunction-drug-sales/ Wed, 26 Aug 2015 12:12:00 GMT New research shows that the common allergy drug loratadine (Claritin) could be effective in treating lyme disease http://www.epmmagazine.com/news/claritin-may-starve-lyme-disease/ http://www.epmmagazine.com/news/claritin-may-starve-lyme-disease/ Tue, 25 Aug 2015 11:53:00 GMT The market release of a pharmaceutical product is achieved by ensuring it has met its product specification, which varies dependent on the type and use of the product, says Wickham Laboratories’ Louise Rigden http://www.epmmagazine.com/news/the-market-release-of-a-pharmaceutical-product-is-achieved-b/ http://www.epmmagazine.com/news/the-market-release-of-a-pharmaceutical-product-is-achieved-b/ Mon, 24 Aug 2015 14:15:00 GMT A wholly new way to fund life science research, complementing more traditional funding, has launched http://www.epmmagazine.com/news/a-wholly-new-way-to-fund-life-science-research-complementing/ http://www.epmmagazine.com/news/a-wholly-new-way-to-fund-life-science-research-complementing/ Fri, 21 Aug 2015 10:04:00 GMT The pharmaceutical sector is required to dispose of waste medicines, and the disposal route must completely conform to compliance requirements http://www.epmmagazine.com/news/pharma-waste-disposal-are-you-in-the-know/ http://www.epmmagazine.com/news/pharma-waste-disposal-are-you-in-the-know/ Fri, 21 Aug 2015 09:37:00 GMT Dave Gray Lu Rahman A UK-based life science team is behind a new campaign – #LetsGetDigital – to get doctors using smart devices in hospitals and surgeries. http://www.epmmagazine.com/news/making-digital-health-a-reality/ http://www.epmmagazine.com/news/making-digital-health-a-reality/ Wed, 19 Aug 2015 11:48:00 GMT Allergan, a global pharmaceutical company, has completed the acquisition of Oculeve http://www.epmmagazine.com/news/allergan-acquires-oculeve-for-dry-eye-care/ http://www.epmmagazine.com/news/allergan-acquires-oculeve-for-dry-eye-care/ Wed, 19 Aug 2015 09:00:00 GMT NICE has published its first guidance in the UK over antibiotics prescriptions http://www.epmmagazine.com/news/gps-to-be-questioned-over-antibiotic-prescriptions/ http://www.epmmagazine.com/news/gps-to-be-questioned-over-antibiotic-prescriptions/ Tue, 18 Aug 2015 11:26:00 GMT Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Relypsa, have announced a partnership to commercialise Relypsa's investigational medicine for the treatment of hyperkalaemia http://www.epmmagazine.com/news/relypsa-forms-partnership-for-hyperkalaemia-treatment/ http://www.epmmagazine.com/news/relypsa-forms-partnership-for-hyperkalaemia-treatment/ Tue, 18 Aug 2015 09:00:00 GMT Antibiotic Research UK will announce at its Annual General meeting today its first research programme to tackle superbugs http://www.epmmagazine.com/news/Antibiotic-Research-UK-superbugs/ http://www.epmmagazine.com/news/Antibiotic-Research-UK-superbugs/ Mon, 17 Aug 2015 11:47:00 GMT New findings forecast global pharma sales to grow past 2014’s $1 trillion to $1.3 trillion by 2018 http://www.epmmagazine.com/news/pharma-sales-to-grow-beyond-1-trillion/ http://www.epmmagazine.com/news/pharma-sales-to-grow-beyond-1-trillion/ Mon, 17 Aug 2015 09:00:00 GMT CPhI, a division of UBM EMEA, and UBM Sinexpo have released the findings of their Pharma Insights China 2015 report http://www.epmmagazine.com/news/cphi-china-report-reveals-survey-findings/ http://www.epmmagazine.com/news/cphi-china-report-reveals-survey-findings/ Thu, 13 Aug 2015 11:53:00 GMT User-friendly, oral solid dosage developer Hermes Pharma is ramping up its expansion in the US market http://www.epmmagazine.com/news/hermes-pharma-forms-dedicated-us-team/ http://www.epmmagazine.com/news/hermes-pharma-forms-dedicated-us-team/ Thu, 13 Aug 2015 10:29:00 GMT Protein engineering company Codexis has entered into a research and development agreement with a leading global biopharmaceutical company http://www.epmmagazine.com/news/codexis-partners-with-biopharma-company/ http://www.epmmagazine.com/news/codexis-partners-with-biopharma-company/ Wed, 12 Aug 2015 15:41:00 GMT UK startup MediSieve is working on a magnetic blood filtering device that captures and removes malaria infected red cells http://www.epmmagazine.com/news/magnetic-blood-filter-to-up-fight-against-malaria/ http://www.epmmagazine.com/news/magnetic-blood-filter-to-up-fight-against-malaria/ Wed, 12 Aug 2015 11:50:00 GMT Cogent Skills' recent Labour Force Survey has shown that the UK life sciences sector is severely lacking in young talent. This has prompted EPM to seek out and compile a list of five youngsters who appear to be bucking this trend. http://www.epmmagazine.com/news/young-and-gifted-five-ones-to-watch/ http://www.epmmagazine.com/news/young-and-gifted-five-ones-to-watch/ Tue, 11 Aug 2015 15:42:00 GMT Twelve new treatments, diagnostics and medical technologies will receive funding from the eighth round of the Biomedical Catalyst (BMC) http://www.epmmagazine.com/news/round-8-of-biomedical-catalyst-awards-announced/ http://www.epmmagazine.com/news/round-8-of-biomedical-catalyst-awards-announced/ Tue, 11 Aug 2015 09:19:00 GMT Pfizer has offered to refund practices for the cost of switching prescriptions of pregabalin over to the brand name as part of an ongoing legal action over the patent of the drug http://www.epmmagazine.com/news/pfizer-to-reimburse-gps-for-switching-prescriptions/ http://www.epmmagazine.com/news/pfizer-to-reimburse-gps-for-switching-prescriptions/ Tue, 11 Aug 2015 08:58:08 GMT Throughout the ages, numerous toxins courtesy of mother nature have been found to offer various health benefits. Here, EPM looks at five potentially deadly poisons that could be, or have been, proved by scientists to better or save lives. http://www.epmmagazine.com/news/five-poisons-that-save-lives/ http://www.epmmagazine.com/news/five-poisons-that-save-lives/ Mon, 10 Aug 2015 16:32:00 GMT A new website has gone live integrating all British Pharmacopoeia content into one resource http://www.epmmagazine.com/news/british-pharmacopoeia-launches-new-website/ http://www.epmmagazine.com/news/british-pharmacopoeia-launches-new-website/ Mon, 10 Aug 2015 16:11:00 GMT Injectables manufacturer Symbiosis Pharmaceutical Services has reported a successful Medicines and Healthcare products Regulatory Agency (MHRA) inspection. http://www.epmmagazine.com/news/sterile-inspection-success-for-symbiosis/ http://www.epmmagazine.com/news/sterile-inspection-success-for-symbiosis/ Mon, 10 Aug 2015 11:53:00 GMT The UK BioIndustry Association (BIA) has published the report The Biomedical Catalyst: making the case to continue. http://www.epmmagazine.com/news/report-calls-for-bmc-scheme-to-continue/ http://www.epmmagazine.com/news/report-calls-for-bmc-scheme-to-continue/ Mon, 10 Aug 2015 10:10:00 GMT The consortium will connect the intellectual know-how of Cambridge researchers with the drug-developing potential of the pharmaceutical industry, to deliver better drugs to the clinic http://www.epmmagazine.com/news/therapeutics-consortium-to-develop-and-study-early-stage-dru/ http://www.epmmagazine.com/news/therapeutics-consortium-to-develop-and-study-early-stage-dru/ Fri, 07 Aug 2015 15:57:00 GMT Cancer Research UK’s Drug Discovery Committee has awarded Newcastle University’s Northern Institute of Cancer Research £5 million to bring more cancer drugs to clinical trials. http://www.epmmagazine.com/news/newcastle-gets-5m-to-boost-drug-development/ http://www.epmmagazine.com/news/newcastle-gets-5m-to-boost-drug-development/ Fri, 07 Aug 2015 09:48:00 GMT David Emm, principal security researcher at software and security group Kaspersky Lab, has warned that the FDA's approval of 3D printing drugs is not necessarily a good thing. http://www.epmmagazine.com/news/a-downside-to-3d-printing-of-drugs/ http://www.epmmagazine.com/news/a-downside-to-3d-printing-of-drugs/ Thu, 06 Aug 2015 12:52:00 GMT The EU has approved Pfizer's $15 billion takeover of US rival Hospira after the pharma giant promised to sell certain drugs in light of competition concerns. http://www.epmmagazine.com/news/eu-approves-pfizers-buyout-of-hospira/ http://www.epmmagazine.com/news/eu-approves-pfizers-buyout-of-hospira/ Thu, 06 Aug 2015 11:03:00 GMT Pfizer and Flynn Pharma stand accused of overcharging the NHS millions for an anti-epilepsy drug. http://www.epmmagazine.com/news/pfizer-and-flynn-in-overcharging-scandal/ http://www.epmmagazine.com/news/pfizer-and-flynn-in-overcharging-scandal/ Thu, 06 Aug 2015 10:19:00 GMT The FDA has approved the first 3D printed drug, Aprecia Pharmaceuticals' Spritam. http://www.epmmagazine.com/news/3d-printed-drug-receives-fda-seal-of-approval/ http://www.epmmagazine.com/news/3d-printed-drug-receives-fda-seal-of-approval/ Wed, 05 Aug 2015 09:39:00 GMT GlaxoSmithKline (GSK) has partnered with the Francis Crick Institute on an open science collaboration, the aim of which is to forge new scientific discoveries. http://www.epmmagazine.com/news/gsk-and-francis-crick-become-partners-in-discovery/ http://www.epmmagazine.com/news/gsk-and-francis-crick-become-partners-in-discovery/ Tue, 04 Aug 2015 14:52:00 GMT